Neo-Concept International Group Holdings Limited Ordinary Shares
NASDAQ: NCI · CONSUMER CYCLICAL · APPAREL MANUFACTURING
Updated 2026-04-29
Neo-Concept International Group Holdings Limited Ordinary Shares (NCI) Stock Valuation Analysis
Fair value estimate, historical valuation range, and quality signals for NCI.
Valued
Valuation reasonably reflects current fundamentals. Limited margin of safety at these levels.
NCI historical valuation range
Where current P/E sits in NCI's own 5Y range.
NCI intrinsic value (DCF)
DCF-based fair value estimate vs current market price.
Intrinsic value calculated using discounted cash flow (DCF) model based on projected free cash flows, discount rate, and terminal growth assumptions. A positive margin of safety indicates the current price is below estimated fair value, providing a cushion against estimation error.
NCI valuation signals
Quick-read green flags, caution flags, and risks based on current metrics.
P/E Ratio — History
Current: 3.39x
P/S Ratio — History
Current: 0.08x
Is NCI overvalued in 2026?
Neo-Concept International Group Holdings Limited Ordinary Shares (NCI) currently trades at $0.95 per share with a market capitalization of $17,970,200.00. Based on our multi-factor framework, the stock trades at a fair valuation with a Smart Value Score of 52/100. This score blends growth quality, financial health, and price attractiveness into a single institutional-grade read.
The stock trades at a P/E ratio of 3.4x. The PEG ratio of 1.13 points to a price that reasonably reflects expected earnings growth.
Our discounted cash flow model estimates NCI's intrinsic value at $16.32 per share, against the current market price of $0.95. This implies a margin of safety of +85.36%. A meaningful cushion exists against model error, making this a reasonable risk-adjusted entry.
The Piotroski F-Score of 4/9 puts financial quality in a middling range, neither a standout strength nor an obvious red flag.
Bottom line: NCI trades at a fair valuation on our framework, with a Smart Value Score of 52/100. The valuation is defensible but offers no obvious bargain. Patience or a better entry price may reward disciplined buyers.
Frequently asked questions
Is NCI overvalued in 2026?
Based on a Smart Value Score of 52/100, NCI is fairly valued. Price reasonably reflects current fundamentals with limited cushion in either direction.
What is NCI's fair value?
Our DCF model estimates NCI's intrinsic value at $16.32 per share, versus the current price of $0.95. This produces a margin of safety of +85.36%.
What P/E ratio does NCI trade at?
NCI trades at a P/E of 3.4x on trailing twelve-month earnings.
Is NCI a buy based on valuation?
WallStSmart does not issue buy or sell recommendations. Our Smart Value Score of 52/100 reflects the combined read on growth, quality, and price. The profile is balanced. Best suited for investors with an existing thesis.
How does NCI's valuation compare to its history?
Insufficient historical valuation data exists yet for a confident percentile read on NCI.
What is NCI's Smart Value Score?
NCI's Smart Value Score is 52/100. The Smart Value Score is a proprietary WallStSmart metric blending growth quality, financial health, and valuation attractiveness into a single 0-100 read. Scores above 75 are rare and indicate strong multi-factor alignment.